The Analogue Advantage: A Smarter Way to derive the market uptake and New Product revenue Forecast
Background: Launching a new therapy in the oncology space is one of the most complex and challenging in the pharma and biotech industries. With evolving treatment landscapes, shifting market dynamics ...
From Evidence to Impact: How Thelansis Accelerated a Rare Disease Submission
Introduction: In recent years, the healthcare landscape has evolved toward an evidence-based, patient-centric architecture. Although conventional clinical trials remain the gold standard, they do not ...
Anticipating the Next Move: AI at the Core of Competitive Intelligence
Introduction: In today's competitive pharmaceutical industry, success relies on anticipating market changes. With rapidly growing data sources, AI-powered data analytics solutions, and predictive mod ...
Next-Gen Data Access for Pharma: How Integrated Data Ecosystems Are Powering Global Pharma Decision-Making
Introduction: In today’s dynamic pharmaceutical landscape, the need for seamless data access and faster decision-making has made AI-powered, cloud-based solutions a cornerstone of innovation. As a ph ...
From Data to Drug: How AI Transformed Clinical Trial Outcomes
Introduction: Drug discovery is a complicated, time-intensive, and expensive undertaking, fraught with vast uncertainty. Even with advancements in science and technology, many drug development progra ...